1-17 of 17
Juris J. Meier
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effect of Oral Semaglutide Versus Comparators on Multiple Cardiometabolic Risk Factor Control in Adults With Type 2 Diabetes

Vanita R. Aroda, Brian Malling, Juris J. Meier, Morten T. Abildlund, Pranav Kelkar, Tina Vilsbøll, Kamlesh Khunti
Journal: Diabetes Care
Diabetes Care dc242373
https://doi.org/10.2337/dc24-2373
Published: 10 March 2025
View article titled, Effect of Oral Semaglutide Versus Comparators on Multiple Cardiometabolic Risk Factor Control in Adults With Type 2 Diabetes
Open the PDF for Effect of Oral Semaglutide Versus Comparators on Multiple Cardiometabolic Risk Factor Control in Adults With Type 2 Diabetes in another window
Journal Articles

Day-to-Day Variations in Fasting Plasma Glucose Do Not Influence Gastric Emptying in Subjects With Type 1 Diabetes

Lea Aigner, Björn Becker, Sonja Gerken, Daniel R. Quast, Juris J. Meier, Michael A. Nauck
Journal: Diabetes Care
Diabetes Care 2021;44(2):479–488
https://doi.org/10.2337/dc20-1660
Published: 07 December 2020
View article titled, Day-to-Day Variations in Fasting Plasma Glucose Do Not Influence Gastric Emptying in Subjects With Type 1 Diabetes
Open the PDF for Day-to-Day Variations in Fasting Plasma Glucose Do Not Influence Gastric Emptying in Subjects With Type 1 Diabetes in another window
Journal Articles

Reduced COVID-19 Mortality With Sitagliptin Treatment? Weighing the Dissemination of Potentially Lifesaving Findings Against the Assurance of High Scientific Standards

Michael A. Nauck, Juris J. Meier
Journal: Diabetes Care
Diabetes Care 2020;43(12):2906–2909
https://doi.org/10.2337/dci20-0062
Published: 08 October 2020
View article titled, Reduced COVID-19 Mortality With Sitagliptin Treatment? Weighing the Dissemination of Potentially Lifesaving Findings Against the Assurance of High Scientific Standards
Open the PDF for Reduced COVID-19 Mortality With Sitagliptin Treatment? Weighing the Dissemination of Potentially Lifesaving Findings Against the Assurance of High Scientific Standards in another window
Journal Articles

Switching From Insulin Bolus Treatment to GLP-1 RAs Added to Continued Basal Insulin in People With Type 2 Diabetes on Basal-Bolus Insulin

Geremia B. Bolli, Francesca Porcellati, Juris J. Meier
Journal: Diabetes Care
Diabetes Care 2020;43(10):2333–2335
https://doi.org/10.2337/dci20-0038
Published: 11 September 2020
View article titled, Switching From Insulin Bolus Treatment to GLP-1 RAs Added to Continued Basal Insulin in People With Type 2 Diabetes on Basal-Bolus Insulin
Open the PDF for Switching From Insulin Bolus Treatment to GLP-1 RAs Added to Continued Basal Insulin in People With Type 2 Diabetes on Basal-Bolus Insulin in another window
Journal Articles

Efficacy and Safety of Short- and Long-Acting Glucagon-Like Peptide 1 Receptor Agonists on a Background of Basal Insulin in Type 2 Diabetes: A Meta-analysis

Jessica A. Huthmacher, Juris J. Meier, Michael A. Nauck
Journal: Diabetes Care
Diabetes Care 2020;43(9):2303–2312
https://doi.org/10.2337/dc20-0498
Published: 11 August 2020
View article titled, Efficacy and Safety of Short- and Long-Acting Glucagon-Like Peptide 1 Receptor Agonists on a Background of Basal Insulin in Type 2 Diabetes: A Meta-analysis
Open the PDF for Efficacy and Safety of Short- and Long-Acting Glucagon-Like Peptide 1 Receptor Agonists on a Background of Basal Insulin in Type 2 Diabetes: A Meta-analysis in another window
Journal Articles

Effects of Lixisenatide Versus Liraglutide (Short- and Long-Acting GLP-1 Receptor Agonists) on Esophageal and Gastric Function in Patients With Type 2 Diabetes

Daniel R. Quast, Nina Schenker, Björn A. Menge, Michael A. Nauck, Christoph Kapitza, Juris J. Meier
Journal: Diabetes Care
Diabetes Care 2020;43(9):2137–2145
https://doi.org/10.2337/dc20-0720
Published: 09 July 2020
View article titled, Effects of Lixisenatide Versus Liraglutide (Short- and Long-Acting GLP-1 Receptor Agonists) on Esophageal and Gastric Function in Patients With Type 2 Diabetes
Open the PDF for Effects of Lixisenatide Versus Liraglutide (Short- and Long-Acting GLP-1 Receptor Agonists) on Esophageal and Gastric Function in Patients With Type 2 Diabetes in another window
Journal Articles

Defects in α-Cell Function in Patients With Diabetes Due to Chronic Pancreatitis Compared With Patients With Type 2 Diabetes and Healthy Individuals

Lena Mumme, Thomas G.K. Breuer, Stephan Rohrer, Nina Schenker, Björn A. Menge, Jens J. Holst, Michael A. Nauck, Juris J. Meier
Journal: Diabetes Care
Diabetes Care 2017;40(10):1314–1322
https://doi.org/10.2337/dc17-0792
Published: 27 July 2017
View article titled, Defects in α-Cell Function in Patients With Diabetes Due to Chronic Pancreatitis Compared With Patients With Type 2 Diabetes and Healthy Individuals
Open the PDF for Defects in α-Cell Function in Patients With Diabetes Due to Chronic Pancreatitis Compared With Patients With Type 2 Diabetes and Healthy Individuals in another window
Includes: Supplementary data
Journal Articles

Empagliflozin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Linagliptin and Metformin: A 24-Week Randomized, Double-Blind, Parallel-Group Trial

Eirik Søfteland, Juris J. Meier, Bente Vangen, Robert Toorawa, Mario Maldonado-Lutomirsky, Uli C. Broedl
Journal: Diabetes Care
Diabetes Care 2017;40(2):201–209
https://doi.org/10.2337/dc16-1347
Published: 02 December 2016
View article titled, Empagliflozin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Linagliptin and Metformin: A 24-Week Randomized, Double-Blind, Parallel-Group Trial
Open the PDF for Empagliflozin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Linagliptin and Metformin: A 24-Week Randomized, Double-Blind, Parallel-Group Trial in another window
Includes: Supplementary data
Journal Articles

Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes on Optimized Insulin Glargine With or Without Metformin: A Randomized, Open-Label Trial

Juris J. Meier, Julio Rosenstock, Agnès Hincelin-Méry, Christine Roy-Duval, Astrid Delfolie, Hans-Veit Coester, Bjoern A. Menge, Thomas Forst, Christoph Kapitza
Journal: Diabetes Care
Diabetes Care 2015;38(7):1263–1273
https://doi.org/10.2337/dc14-1984
Published: 17 April 2015
View article titled, Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes on Optimized Insulin Glargine With or Without Metformin: A Randomized, Open-Label Trial
Open the PDF for Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes on Optimized Insulin Glargine With or Without Metformin: A Randomized, Open-Label Trial in another window
Includes: Supplementary data
Journal Articles

Hyperglycemia Potentiates the Slowing of Gastric Emptying Induced by Exogenous GLP-1

Mark P. Plummer, Karen L. Jones, Caroline E. Cousins, Laurence G. Trahair, Juris J. Meier, Marianne J. Chapman, Michael Horowitz, Adam M. Deane
Journal: Diabetes Care
Diabetes Care 2015;38(6):1123–1129
https://doi.org/10.2337/dc14-3091
Published: 17 March 2015
View article titled, Hyperglycemia Potentiates the Slowing of Gastric Emptying Induced by Exogenous GLP-1
Open the PDF for Hyperglycemia Potentiates the Slowing of Gastric Emptying Induced by Exogenous GLP-1 in another window
Journal Articles

Glucagon-Like Peptide 1 Attenuates the Acceleration of Gastric Emptying Induced by Hypoglycemia in Healthy Subjects

Mark P. Plummer, Karen L. Jones, Chris E. Annink, Caroline E. Cousins, Juris J. Meier, Marianne J. Chapman, Michael Horowitz, Adam M. Deane
Journal: Diabetes Care
Diabetes Care 2014;37(6):1509–1515
https://doi.org/10.2337/dc13-1813
Published: 10 May 2014
View article titled, Glucagon-Like Peptide 1 Attenuates the Acceleration of Gastric Emptying Induced by Hypoglycemia in Healthy Subjects
Open the PDF for Glucagon-Like Peptide 1 Attenuates the Acceleration of Gastric Emptying Induced by Hypoglycemia in Healthy Subjects in another window
Journal Articles

The Effect of Exogenous Glucose-Dependent Insulinotropic Polypeptide in Combination With Glucagon-Like Peptide-1 on Glycemia in the Critically Ill

Michael Y. Lee, BMED SC, Jonathan D. Fraser, MBBS, FCICM, Marianne J. Chapman, BMBS, PHD, FCICM, FANZCA, Krishnaswamy Sundararajan, MBBS, MD, FCICM, Mahesh M. Umapathysivam, BMED SC, Matthew J. Summers, BSC, Antony V. Zaknic, BMED SC, Christopher K. Rayner, MBBS, PHD, FRACP, Juris J. Meier, MD, Michael Horowitz, MBBS, PHD, FRACP, Adam M. Deane, MBBS, PHD, FRACP, FCICM
Journal: Diabetes Care
Diabetes Care 2013;36(10):3333–3336
https://doi.org/10.2337/dc13-0307
Published: 14 September 2013
View article titled, The Effect of Exogenous Glucose-Dependent Insulinotropic Polypeptide in Combination With Glucagon-Like Peptide-1 on Glycemia in the Critically Ill
Open the PDF for The Effect of Exogenous Glucose-Dependent Insulinotropic Polypeptide in Combination With Glucagon-Like Peptide-1 on Glycemia in the Critically Ill in another window
Journal Articles

Role of Reduced β-Cell Mass Versus Impaired β-Cell Function in the Pathogenesis of Type 2 Diabetes

Juris J. Meier, MD, Riccardo C. Bonadonna, MD
Journal: Diabetes Care
Diabetes Care 2013;36(Supplement_2):S113–S119
https://doi.org/10.2337/dcS13-2008
Published: 17 July 2013
View article titled, Role of Reduced β-Cell Mass Versus Impaired β-Cell Function in the Pathogenesis of Type 2 Diabetes
Open the PDF for Role of Reduced β-Cell Mass Versus Impaired β-Cell Function in the Pathogenesis of Type 2 Diabetes in another window
Journal Articles

Chronic Reduction of Fasting Glycemia With Insulin Glargine Improves First- and Second-Phase Insulin Secretion in Patients With Type 2 Diabetes

Christian Pennartz, MD, Nina Schenker, MD, Björn A. Menge, MD, Wolfgang E. Schmidt, MD, Michael A. Nauck, MD, Juris J. Meier, MD
Journal: Diabetes Care
Diabetes Care 2011;34(9):2048–2053
https://doi.org/10.2337/dc11-0471
Published: 19 August 2011
View article titled, Chronic Reduction of Fasting Glycemia With Insulin Glargine Improves First- and Second-Phase Insulin Secretion in Patients With Type 2 Diabetes
Open the PDF for Chronic Reduction of Fasting Glycemia With Insulin Glargine Improves First- and Second-Phase Insulin Secretion in Patients With Type 2 Diabetes in another window
Journal Articles

Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin: A randomized, 52-week, double-blind, active-controlled noninferiority trial

Michael A. Nauck, MD, Stefano Del Prato, MD, Juris J. Meier, MD, Santiago Durán-García, MD, Katja Rohwedder, MD, Martina Elze, MS, Shamik J. Parikh, MD
Journal: Diabetes Care
Diabetes Care 2011;34(9):2015–2022
https://doi.org/10.2337/dc11-0606
Published: 19 August 2011
View article titled, Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin: <subtitle>A randomized, 52-week, double-blind, active-controlled noninferiority trial</subtitle>
Open the PDF for Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin: <subtitle>A randomized, 52-week, double-blind, active-controlled noninferiority trial</subtitle> in another window
Includes: Supplementary data
Journal Articles

Hyperinsulinemic Hypoglycemia After Gastric Bypass Surgery Is Not Accompanied by Islet Hyperplasia or Increased β-Cell Turnover

Juris J. Meier, MD, Alexandra E. Butler, MD, Ryan Galasso, BS, Peter C. Butler, MD
Journal: Diabetes Care
Diabetes Care 2006;29(7):1554–1559
https://doi.org/10.2337/dc06-0392
Published: 01 July 2006
View article titled, Hyperinsulinemic Hypoglycemia After Gastric Bypass Surgery Is Not Accompanied by Islet Hyperplasia or Increased β-Cell Turnover
Open the PDF for Hyperinsulinemic Hypoglycemia After Gastric Bypass Surgery Is Not Accompanied by Islet Hyperplasia or Increased β-Cell Turnover in another window
Journal Articles

Plasma Glucose at Hospital Admission and Previous Metabolic Control Determine Myocardial Infarct Size and Survival in Patients With and Without Type 2 Diabetes: The Langendreer Myocardial Infarction and Blood Glucose in Diabetic Patients Assessment (LAMBDA)

Juris J. Meier, MD, Silvia Deifuss, MD, Andreas Klamann, MD, Volker Launhardt, MD, Wolff H. Schmiegel, MD, PHD, Michael A. Nauck, MD, PHD
Journal: Diabetes Care
Diabetes Care 2005;28(10):2551–2553
https://doi.org/10.2337/diacare.28.10.2551
Published: 01 October 2005
View article titled, Plasma Glucose at Hospital Admission and Previous Metabolic Control Determine Myocardial Infarct Size and Survival in Patients With and Without Type 2 Diabetes: <subtitle>The Langendreer Myocardial Infarction and Blood Glucose in Diabetic Patients Assessment (LAMBDA)</subtitle>
Open the PDF for Plasma Glucose at Hospital Admission and Previous Metabolic Control Determine Myocardial Infarct Size and Survival in Patients With and Without Type 2 Diabetes: <subtitle>The Langendreer Myocardial Infarction and Blood Glucose in Diabetic Patients Assessment (LAMBDA)</subtitle> in another window